Pro-inflammatory immune signaling pathways

Pro-inflammatory immune signaling pathways represent a broad category of biochemical cascades that coordinate the body's response to harmful stimuli, such as pathogens, damaged cells, or irritants (Source: Nature Reviews Immunology, 2017). Key pathways include the Nuclear Factor-kappa B (NF-κB) signaling, the Janus Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) pathway, and various Mitogen-Activated Protein Kinase (MAPK) cascades (Source: NIH, 2023). These pathways facilitate the production of cytokines, chemokines, and other mediators that recruit immune cells to the site of injury or infection. While acute activation is protective, chronic or excessive signaling is a primary driver of autoimmune disorders, chronic inflammatory diseases, and even certain cancers (Source: StatPearls, 2023). Pharmacological intervention typically targets specific components within these pathways, such as cytokine-neutralizing antibodies or small-molecule kinase inhibitors, to restore immune homeostasis (Source: PubMed, 2022). However, because these pathways are integral to host defense, therapeutic modulation carries significant risks, most notably an increased susceptibility to opportunistic infections (Source: FDA, 2021). This broad classification is often used in drug discovery to describe the general mechanism of action for anti-inflammatory agents before a specific molecular target is identified.

Other names

Inflammatory signaling cascadesPro-inflammatory pathwaysImmune activation pathwaysInflammatory signaling networks

Inhibition of specific signaling nodes, including cytokine ligands, cell-surface receptors, or intracellular kinases, to dampen the inflammatory response.